EndocrineWatch
An advisory platform that helps organizations stay ahead of endocrine disruptor and reprotoxin risks — before they become regulatory crises or reputational disasters.
Built on a high-quality, expert-curated database rooted in developmental and reproductive toxicology(DART), EndocrineWatch delivers detailed chemical profiles with US/EU regulatory status, mechanistic reasoning, and direct links to human health impacts.
Get the depth and clarity that only true domain expertise can provide so you can make faster, more confident decisions on compliance, formulation, and product safety.
What Is DART?
In toxicology and regulatory science, DART stands for Developmental and Reproductive Toxicity. It describes the potential of chemical substances to cause adverse effects on the development of the embryo, fetus, or offspring, including structural malformations, growth reduction, or functional deficits. It also encompasses impairment of reproductive capacity in exposed adults, covering impacts on gamete production and quality, hormone balance, and offspring viability.
Why Use EndocrineWatch?
In today’s regulatory environment, a single overlooked endocrine disruptor, reprotoxin or DART toxicant in your product lineup can trigger devastating consequences: multimillion-dollar recalls, forced market withdrawals, and reputational damage that erodes consumer trust.
EndocrineWatch gives you a clear advantage, a proactive intelligence layer with curated chemical profiles, real-time US/EU ban status, mechanistic reasoning, and health-risk mapping, so you can identify and mitigate these exposures before they reach the shelf. Instead of reacting to a crisis, you stay ahead of it, protecting your brand, your bottom line, and your ability to innovate with confidence.
Regulatory agencies on both sides of the Atlantic are accelerating enforcement—EU Omnibus amendments, state-level bans in California, New York, and Hawaii, and evolving FDA scrutiny mean that yesterday’s compliant formula can become tomorrow’s compliance violation overnight. Ensure your company avoids that outcome, with EndocrineWatch.
"Healthcare insights in EndocrineWatch....capture the spirit of innovation that defines HVTechFest."
- HVTechFest 2025, Rensselaer Polytechnic Institute
Plan Tiers
EndocrineWatch is available through structured pricing tiers reflecting scope of access and intended use.
Professional
For researchers, consultants, and individual members of small teams
Full access to the EndocrineWatch interface, including curated chemical profiles, endocrine-disruption/DART reasoning, US/EU regulatory status, and linked scientific references.
Designed for independent researchers, regulatory consultants, and other individuals requiring reliable, citation-ready endocrine intelligence.
Includes regular dataset updates, ingredient/version history auditing features, and search by INCI Name or CAS Number.
Enterprise
For companies using EndocrineWatch in compliance and risk decisions
Organization-wide access to EndocrineWatch for internal regulatory, formulation, and risk-assessment workflows.
Includes everything in the Professional tier, plus regulatory trajectory tracking, and priority updates as scientific or regulatory positions evolve.
Enterprise-exclusive information and features are provided through a dedicated interface available only to licensed Enterprise customers.
Data Integration
For teams embedding EndocrineWatch into internal systems and/or AI pipelines
Licensed access to the underlying curated dataset in machine-readable formats, suitable for internal tools, screening pipelines, analytical platforms and AI automation.
Intended for organizations that require endocrine-disruption intelligence programmatically rather than through the standalone interface.
Integration options, update cadence, and dataset scope are customized based on use case and deployment requirements.
To book a demo or exploratory meeting, fill out the form below.
Alternatively, directly email info@androfastbiologics.com.